Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 1 of this Exclusive Interview, Dr. Handelsman explains the necessity of a comprehensive approach when it comes to the physicians' management of diabetes.

In Part 2 of this exclusive interview, Dr. Robert Geho discusses the Phase 2b study which focuses on adding Diasome's HDV to a leading pre-meal fast acting analogue.

In part one of this exclusive interview, Dr. Robert Geho discusses the essential role of the liver in metabolizing insulin, and asks why we hear about the artificial pancreas all the time, but never hear anyone talk about an artificial liver?

In Part 7, the final installment of this Exclusive Interview from the 2016 Diabetes Symposium in Boston, Dr. Robert Geho explains the potential marketing and timing of the product offering. Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc.  In his role at Diasome, he leads the …

In Part 6 of this Exclusive Interview from the 2016 Diabetes Symposium in Boston, Dr. Robert Geho and Diabetes in Control publisher Steve Freed discuss the possible reduction in the use of insulin as well  as hypoglycemia following the use of the product. Robert Geho, MD, is a co-founder and CEO …

In Part 5 of this Exclusive Interview from the 2016 Diabetes Symposium in Boston, Dr. Robert Geho explains the potential effect of the proper storage of insulin within the liver on the overall weight of the patient. Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc.  In …

In Part 4 of this Exclusive Interview from the 2016 Diabetes Symposium in Boston, understanding the best insulin for the admixture and the possible effect on A1C. Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc.  In his role at Diasome, he leads the management and strategic …

In Part 3 of this Exclusive Interview from the 2016 Diabetes Symposium in Boston, Dr. Robert Geho explains the focus on the phase of trials. Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc.  In his role at Diasome, he leads the management and strategic direction of …

In Part 2 of this Exclusive Interview from the 2016 Diabetes Symposium in Boston, Dr. Robert Geho explains the effect of insulin on the liver. Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc.  In his role at Diasome, he leads the management and strategic direction of …

In Part 1 of this Exclusive Interview, Dr. Robert Geho joins Diabetes in Control publisher Steve Freed at the 2016 Diabetes Symposium in Boston to discuss a new drug delivery system designed to deliver insulin molecules that are currently sold as commercial insulins to cells in the liver. Robert Geho, …